SCM
Suvretta Capital Management Portfolio holdings
AUM
$2.65B
This Quarter Return
+0.16%
1 Year Return
+18.59%
3 Year Return
+180.23%
5 Year Return
+278.12%
10 Year Return
+1,101.07%
AUM
$5.88B
AUM Growth
+$5.88B
(-12%)
Cap. Flow
-$648M
Cap. Flow
% of AUM
-11.02%
Top 10 Holdings %
Top 10 Hldgs %
40.93%
Holding
144
New
23
Increased
39
Reduced
15
Closed
39
Top Buys
| 1 |
Thermo Fisher Scientific
TMO
|
$186M |
| 2 |
Alight
ALIT
|
$95.9M |
| 3 |
XYZ
Block, Inc.
XYZ
|
$72.7M |
| 4 |
Twilio
TWLO
|
$64.6M |
| 5 |
Opendoor
OPEN
|
$56.3M |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
$269M |
| 2 |
Uber
UBER
|
$193M |
| 3 |
Meta Platforms (Facebook)
META
|
$161M |
| 4 |
Paysafe
PSFE
|
$156M |
| 5 |
Apple
AAPL
|
$99.6M |
Sector Composition
| 1 | Healthcare | 32.65% |
| 2 | Consumer Discretionary | 19.24% |
| 3 | Technology | 18.68% |
| 4 | Industrials | 18.41% |
| 5 | Financials | 4.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Natera
NTRA
$23B
| $83.3M | 1.4% |
747,220
+393,520
| +111% | +$43.9M |
|
27
TE Connectivity
TEL
$60.9B
| $82.9M | 1.4% |
603,877
-650
| -0.1% | -$89.2K |
|
28
Analog Devices
ADI
$120B
| $80M | 1.35% |
477,645
+166,005
| +53% | +$27.8M |
|
29
Howmet Aerospace
HWM
$70.3B
| $79.6M | 1.34% |
2,551,230
+890,430
| +54% | +$27.8M |
|
|
XYZ
30
Block, Inc.
XYZ
$46.2B
| $72.7M | 1.22% |
+302,930
| New | +$72.7M |
|
31
Agios Pharmaceuticals
AGIO
$2.36B
| $60.5M | 1.02% |
1,311,748
+324,292
| +33% | +$15M |
|
32
Royalty Pharma
RPRX
$15.8B
| $55.2M | 0.93% |
1,527,900
+798,523
| +109% | +$28.9M |
|
33
Fulcrum Therapeutics
FULC
$353M
| $54.8M | 0.92% |
1,941,969
+314,525
| +19% | +$8.87M |
|
34
Warby Parker
WRBY
$3.08B
| $53.1M | 0.89% |
+1,000,000
| New | +$53.1M |
|
35
NXP Semiconductors
NXPI
$57.5B
| $50.2M | 0.85% |
256,438
-147,990
| -37% | -$29M |
|
|
ITCI
36
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $46.7M | 0.79% |
1,251,946
+213,176
| +21% | +$7.95M |
|
37
Kura Oncology
KURA
$732M
| $46.1M | 0.78% |
2,460,202
+801,496
| +48% | +$15M |
|
38
Sutro Biopharma
STRO
$85.6M
| $42.2M | 0.71% |
2,233,695
+518,314
| +30% | +$9.79M |
|
39
Elastic
ESTC
$9.17B
| $40.4M | 0.68% |
+271,000
| New | +$40.4M |
|
|
MRTX
40
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $33.8M | 0.57% |
191,308
+42,436
| +29% | +$7.51M |
|
|
ARNA
41
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $30.2M | 0.51% |
+507,088
| New | +$30.2M |
|
|
DCPH
42
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $29.3M | 0.49% |
862,126
+209,491
| +32% | +$7.12M |
|
43
Insmed
INSM
$30.3B
| $27.5M | 0.46% |
998,732
+557,667
| +126% | +$15.4M |
|
44
KalVista Pharmaceuticals
KALV
$713M
| $26.9M | 0.45% |
1,543,284
+352,183
| +30% | +$6.15M |
|
|
MRNS
45
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $25M | 0.42% |
2,197,426
+370,981
| +20% | +$4.22M |
|
|
MREO
46
Mereo BioPharma
MREO
$275M
| $22.1M | 0.37% |
9,142,067
+492,767
| +6% | +$1.19M |
|
|
TE
47
T1 Energy Inc.
TE
$285M
| $20.7M | 0.35% |
+2,093,710
| New | +$20.7M |
|
48
EyePoint Pharmaceuticals
EYPT
$827M
| $17.8M | 0.3% |
1,704,589
+326,257
| +24% | +$3.4M |
|
49
Xenon Pharmaceuticals
XENE
$2.99B
| $17.7M | 0.3% |
1,158,961
+564,850
| +95% | +$8.63M |
|
50
Spyre Therapeutics
SYRE
$1.02B
| $17.2M | 0.29% |
2,157,727
+63,627
| +3% | +$506K |
|